Evidence map›Paper›PMID 42147311›Full record

ReviewFrontiers in pharmacology2026

Advances in plant polysaccharides in cancer therapy targeting ferroptosis.

Yutong Li, Chong Zhou, Ziwei Wang, Wei Ni, Hao Xu, Yingjie Xing, Li Huang

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yutong LiInstitute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Chong ZhouCollege of Basic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Ziwei WangInstitute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Wei NiInstitute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Hao XuCollege of Basic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Yingjie XingCollege of Basic Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Li HuangInstitute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, Guangxi University of Chinese Medicine, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a global health public issue with an increasing morbidity and mortality. Ferroptosis is a form of regulated cell death characterized by iron accumulation and lipid peroxidation, providing a novel and promising strategy for cancer treatment. Plant polysaccharides possess low toxicity, minimal side effects, and significant therapeutic potential, particularly in antioxidation, immune regulation, and cancer suppression. However, it is unknown that whether and how ferroptosis is involved in the anticancer effects of plant polysaccharides. Occurrence of ferroptosis in cancer cells involves with several cell events including disturbed iron metabolism, overwhelmed lipid metabolism, and disordered antioxidant defense, which is fatal to cancer cells. Recent studies have showed that plant polysaccharides play significant roles in cancer treatment with activities in ferroptosis regulation through inhibiting cancer growth, enhancing treatment sensitivity, reducing drug resistance, strengthening immune function. This review presents the current understanding of polysaccharides regulation in cancer treatment targeting ferroptosis, and also address the limitation and future direction of polysaccharide application regarding cancer treatment via ferroptosis. These findings would contribute to advancing cancer therapy.

Indexed as

cancer therapyferroptosisplant polysaccharidereviewtraditional Chinese medicine

Identifiers

PMID42147311
PMCPMC13176307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.